168 related articles for article (PubMed ID: 33628340)
1. Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer.
Wang Z; Wang S; Liu Y; Gao S; Yu Y; Hu Z
Dis Markers; 2021; 2021():8867368. PubMed ID: 33628340
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients.
Brierley GV; Priebe IK; Purins L; Fung KY; Tabor B; Lockett T; Nice E; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Burgess A; Cosgrove LJ
Cancer Biomark; 2013; 13(2):67-73. PubMed ID: 23838134
[TBL] [Abstract][Full Text] [Related]
3. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
4. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
[TBL] [Abstract][Full Text] [Related]
5. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
6. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
7. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
Pasha HF; Radwan MI; Yehia AM; Toam MM
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
[TBL] [Abstract][Full Text] [Related]
8. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.
Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z
World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143
[TBL] [Abstract][Full Text] [Related]
10. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
11. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
Naicker YD; Moolla Z; Madiba T
Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
[TBL] [Abstract][Full Text] [Related]
12. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
13. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
15. SALL4 as a new biomarker for early colorectal cancers.
Ardalan Khales S; Abbaszadegan MR; Abdollahi A; Raeisossadati R; Tousi MF; Forghanifard MM
J Cancer Res Clin Oncol; 2015 Feb; 141(2):229-35. PubMed ID: 25156818
[TBL] [Abstract][Full Text] [Related]
16. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
17. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.
Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
19. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
20. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]